Overview

Discovery Services Market Introduction

Global Drug Discovery Services Market is estimated to value over USD 15.1 billion by 2027 end and register a CAGR of over 10.6% during the forecast period 2020 to 2027.

The process of developing a new drug is known as drug discovery. The most widely implemented methods used for discovering drugs are molecular designing, serendipity, drug metabolites, molecular manipulation and random screening. The services associated with drug discovery are particularly designed in order to minimize the timelines and costs of drug discovery.

The growing insistence for various cancer treatments, advancements in technology and rising expenditure of healthcare are the crucial factors steering the drug discovery services market growth. As per the WHO, cancer is one of the primary cause of death across the world. The disease has resulted in over 8 million deaths in 2016. The commonly diagnosed cancers are colorectal cancer, stomach cancer, breast cancer, lung cancer and liver cancer. Infections that causes cancer are the ones responsible for over 23% cancer cases in the middle-income and low-income nations.

Other factors, for instance, the increasing awareness regarding persistent diseases, growing patient population, incomplete medical requirements, patent of blockbuster drugs getting expired, an inflating framework of the regulations, rising government assistance, and rising funding and reimbursement are continuously contributing to the growth of the drug discovery services market.

However, there are some restraints associated with the market. Huge investments with low or no profits margins, stringent regulations by the FDA, and inferior healthcare system in middle and low-income nations may impede the drug discovery services market growth to a significant extent.

North America dominates the global market due to the rising presence of persistent diseases and hefty expenditure associated with healthcare. As per the data provided by the centre for disease control and prevention (CDC), over 90 million adults have at least one cardiovascular disease. Furthermore, it is reported that over 16 % of adults in the U.S smoked cigarettes in 2016, which held for more than 490,000 deaths each year. Over 86% of the healthcare cost in the United States i.e. over USD 2.5 trillion is spent for people with mental and chronic health conditions.

Key market players involved in the global drug discovery services industry are Thermo Fisher Scientific, Merck, GE Healthcare, Albany Molecular Research, Inc. (AMRI), Charles River Laboratories International, Evotec, Pharmaceutical Product Development, LLC. (Ppd), Jubilant Biosys, Covance, Genscript Biotech Corporation, Aurigene Discovery Technologies, Wuxi Apptec, Syngene

Drug Discovery Services Market Segmentation:

By Process

• Target Selection

• Target Validation

• Hit-to-Lead Identification

• Lead Optimization

• Candidate Validation

By Type

• Medicinal Chemistry

• Biology Services

• Drug Metabolism and Pharmacokinetics

By Drug Type

• Small Molecules

• Biologics

By Therapeutic Area

• Oncology

• Neurology

• Cardiovascular Diseases

• Respiratory Diseases

• Diabetes

• Other Therapeutics Areas

By Region

• North America

• Europe

• Asia Pacific

• Rest of the world

FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the drug discovery services market by process, by type, by drug type, by therapeutic area and by region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

1.3 Market Scope 

        1.3.1 Markets Covered

        1.3.2 Years Considered for the Study

1.4 Currency 

1.5 Limitations 

1.6 Stakeholders 

2 Research Methodology 

2.1 Research Data 

2.2 Secondary Data 

        2.2.1 Key Data From Secondary Sources

2.3 Primary Data 

        2.3.1 Key Data From Primary Sources

2.4 Market Size Estimation 

        2.4.1 Bottom-Up Approach

        2.4.2 Top-Down Approach

2.5 Data Triangulation 

2.6 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 

4.1 Drug Discovery Services Market Overview 

4.2 European Market Share, By Therapeutic Area and Country 

4.3 Global Market, By Type 

4.4 Geographical Snapshot of the Global Market 

5 Market Overview 

5.1 Introduction 

5.2 Market Dynamics 

        5.2.1 Drivers

                 5.2.1.1 Increasing R&D Expenditure

                 5.2.1.2 Increasing Demand for Outsourcing Analytical Testing and Clinical Trial Services

                 5.2.1.3 Initiatives for Research on Rare Diseases

                 5.2.1.4 Focus on Drug Discovery

        5.2.2 Restraints

                 5.2.2.1 High Cost of Drug Discovery and Development

                 5.2.2.2 Stringent Regulations Governing Drug Discovery, and Animal Usage

        5.2.3 Opportunities

                 5.2.3.1 Introduction of Advanced Technologies

                 5.2.3.2 Patent Expiries to Boost the Demand for Drug Discovery

        5.2.4 Burning Issues

                 5.2.4.1 Need for Harmonization of Regulations, Ip Rights

6 Drug Discovery Services Market, By Process 

6.1 Introduction 

6.2 Target Selection 

6.3 Target Validation 

6.4 Hit-To-Lead Identification 

6.5 Lead Optimization 

6.6 Candidate Validation 

7 Drug Discovery Services Market, By Type 

7.1 Introduction 

7.2 Medicinal Chemistry 

7.3 Biology Services 

7.4 Drug Metabolism and Pharmacokinetics (DMPK) 

8 Drug Discovery Services Market, By Drug Type 

8.1 Introduction 

8.2 Small Molecules 

8.3 Biologics 

9 Drug Discovery Services Market, By Therapeutic Area 

9.1 Introduction 

9.2 Oncology 

9.3 Neurology 

9.4 Cardiovascular Diseases 

9.5 Respiratory Diseases 

9.6 Diabetes 

9.7 Other Therapeutic Areas 

10 Drug Discovery Services Market, By Region 

  10.1 Introduction 

  10.2 North America 

          10.2.1 US

          10.2.2 Canada

  10.3 Europe 

          10.3.1 Germany

          10.3.2 UK

          10.3.3 France

          10.3.4 Rest of Europe (RoE)

  10.4 Asia Pacific (APAC) 

          10.4.1 China

          10.4.2 Japan

          10.4.3 India

          10.4.4 Rest of Asia Pacific (RoAPAC)

  10.5 Rest of the World (RoW) 

11 Competitive Landscape 

  11.1 Market Share Analysis 

12 Company Profiles 

  12.1 Thermo Fisher Scientific 

  12.2 Merck 

  12.3 GE Healthcare 

  12.4 Albany Molecular Research, Inc. (AMRI) 

  12.5 Charles River Laboratories International 

  12.6 Evotec 

  12.7 Pharmaceutical Product Development, LLC. (Ppd) 

  12.8 Jubilant Biosys 

  12.9 Covance 

  12.10 Genscript Biotech Corporation 

  12.11 Aurigene Discovery Technologies 

  12.12 Wuxi Apptec 

  12.13 Syngene

Chapter 13 Research Finding and Conclusion 

Chapter 14  Research Methodology 

Chapter 15  Research Data Source  

Tables

Figures